{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:54:51Z","timestamp":1791824091331,"version":"4.3.4"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease with limited therapeutic options. Tamoxifen, a breast cancer therapeutic agent, raises environmental concerns due to its persistence and bioaccumulation potential, but its role as an endocrine disruptor in IPF pathogenesis remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      We integrated computational toxicity prediction (ProTox-3.0\/ADMETlab-3.0), FDA Adverse Event Reporting System (FAERS) pharmacovigilance, and Mendelian randomization (MR) to establish causal tamoxifen\u2013IPF links. Network toxicology identified shared targets, with protein\u2013protein interactions network construction revealing seven hubgenes. Multi-omics validation included: transcriptomics (GSE110147\/GSE53845) for hubgenes expression, immune infiltration and single-cell RNA (scRNA) sequencing (GSE159354) for cellular associations, and machine learning (least absolute shrinkage and selection operator\/support vector machine-recursive feature elimination\/random forest) for biomarker identification. Mechanistic studies involved miRNA expression data (GSE27430) to explore the upstream regulators of key genes, and molecular docking to validate drug targets. Finally,\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      validation was performed in C57BL\/6 mice administered intraperitoneal tamoxifen, with assessment of pulmonary inflammation and fibrosis using bronchoalveolar lavage fluid protein exudation, cell counts, lung wet\/dry weight ratio, and Ashcroft score, along with evaluation of epidermal growth factor receptor (EGFR)\/phosphorylated EGFR (p-EGFR) and miRNA-432-3p expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Computational toxicity prediction revealed tamoxifen\u2019s high respiratory toxicity potential, corroborated by FAERS-reported lung fibrosis associations, and MR confirmed causal IPF risk. Network toxicology identified seven hubgenes functionally enriched in miRNA regulation, with multi-omics validation revealing a critical EGFR dysregulation pattern where transcriptional downregulation contrasted with post-translational hyperactivation evidenced by elevated p-EGFR in fibrotic lungs. Mechanistically, miR-432-3p was upregulated in IPF and confirmed to directly target EGFR, while molecular docking demonstrated tamoxifen\u2019s preferential binding to miR-432-3p over EGFR. This tamoxifen\u2013miRNA\u2013EGFR axis drove pulmonary fibrosis with concurrent p-EGFR and mmu-miR-432 elevation\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Tamoxifen promotes IPF via miR-432-3p-mediated EGFR suppression, establishing it as a pulmonary toxicant. Integrated network toxicology identifies EGFR as a diagnostic biomarker, highlighting environmental and clinical risks of tamoxifen exposure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003620","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:02:05Z","timestamp":1771869725000},"page":"2696-2716","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Decoding tamoxifen on idiopathic pulmonary fibrosis: integrating network toxicology and multi-omics"],"prefix":"10.1097","volume":"112","author":[{"given":"Yihan","family":"Sun","sequence":"first","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Second College of Clinical Medical, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Lu","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Mathematics, University of California, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Huang","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xie","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yao","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Department of Geriatric Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Huang","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5146-9499","authenticated-orcid":false,"given":"Xiuchun","family":"Li","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"1581\u201393","DOI":"10.1007\/s40265-023-01950-0","article-title":"Current and future treatment landscape for idiopathic pulmonary fibrosis","volume":"83","author":"Bonella","year":"2023","journal-title":"Drugs"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"1811\u201323","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"515\u201346","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis","volume":"17","author":"Moss","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"107798","DOI":"10.1016\/j.pharmthera.2020.107798","article-title":"Idiopathic pulmonary fibrosis: disease mechanisms and drug development","volume":"222","author":"Spagnolo","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"2031\u201357","DOI":"10.1007\/s00018-020-03693-7","article-title":"Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis","volume":"78","author":"Phan","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/biomedicines11010163","article-title":"Role of ferroptosis in regulating the epithelial-mesenchymal transition in pulmonary fibrosis","volume":"11","author":"Ling","year":"2023","journal-title":"Biomedicines"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"12540","DOI":"10.3390\/ijms252312540","article-title":"Molecular mechanism of action of endocrine-disrupting chemicals on the respiratory system","volume":"25","author":"Molinari","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"127\u201347","DOI":"10.1007\/s11154-019-09521-z","article-title":"Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention","volume":"21","author":"Yilmaz","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"120645","DOI":"10.1016\/j.watres.2023.120645","article-title":"Review of Endocrine Disrupting Compounds (EDCs) in China\u2019s water environments: implications for environmental fate, transport and health risks","volume":"245","author":"Xiao","year":"2023","journal-title":"Water Res"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"102375","DOI":"10.1016\/j.ctrv.2022.102375","article-title":"Adjuvant and neoadjuvant breast cancer treatments: a systematic review of their effects on mortality","volume":"105","author":"Kerr","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"R11-20260512","first-page":"343\u201363","article-title":"Inducible Cre mice","volume":"530","author":"Feil","year":"2009","journal-title":"Methods Mol Biol"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"79\u201384","DOI":"10.1016\/j.chemosphere.2015.01.002","article-title":"Tamoxifen ecotoxicity and resulting risks for aquatic ecosystems","volume":"128","author":"Orias","year":"2015","journal-title":"Chemosphere"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"457\u201362","DOI":"10.1016\/j.ecoenv.2015.06.033","article-title":"Bioconcentration of (15)N-tamoxifen at environmental concentration in liver, gonad and muscle of Danio rerio","volume":"120","author":"Orias","year":"2015","journal-title":"Ecotoxicol Environ Saf"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"284\u201392","DOI":"10.1016\/j.chemosphere.2016.10.057","article-title":"Elimination study of the chemotherapy drug tamoxifen by different advanced oxidation processes: transformation products and toxicity assessment","volume":"168","author":"Ferrando-Climent","year":"2017","journal-title":"Chemosphere"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"286\u201393","DOI":"10.1016\/j.jhazmat.2018.07.002","article-title":"Ecotoxicological effects prior to and after the ozonation of tamoxifen","volume":"358","author":"Knoop","year":"2018","journal-title":"J Hazard Mater"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"256\u201372","DOI":"10.1016\/j.envint.2019.05.014","article-title":"Impacts of in vivo and in vitro exposures to tamoxifen: comparative effects on human cells and marine organisms","volume":"129","author":"Fonseca","year":"2019","journal-title":"Environ Int"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"e70313","DOI":"10.1096\/fj.202402553RR","article-title":"Prolonged tamoxifen treatment induces iron deposition and ferroptosis in the liver","volume":"39","author":"Yang","year":"2025","journal-title":"Faseb J"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"42\u201350","DOI":"10.1016\/j.survophthal.2023.07.003","article-title":"Tamoxifen retinopathy: a comprehensive review","volume":"69","author":"Tenney","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"165\u201370","DOI":"10.1007\/s11248-016-9987-8","article-title":"Tamoxifen dosing for Cre-mediated recombination in experimental bronchopulmonary dysplasia","volume":"26","author":"Ruiz-Camp","year":"2017","journal-title":"Transgenic Res"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"297\u2013303","DOI":"10.1177\/00236772211042968","article-title":"Tamoxifen administration induces histopathologic changes within the lungs of Cre-recombinase-negative mice: a case report","volume":"56","author":"Wyatt","year":"2022","journal-title":"Lab Anim"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"186\u201390","DOI":"10.1016\/j.ijscr.2019.02.026","article-title":"Tamoxifen-induced acute eosinophilic pneumonia in a breast cancer patient","volume":"60","author":"Kwon","year":"2019","journal-title":"Int J Surg Case Rep"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"2903\u201306","DOI":"10.2169\/internalmedicine.8649-16","article-title":"Tamoxifen-induced lung injury","volume":"56","author":"Etori","year":"2017","journal-title":"Intern Med"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"449\u201359","DOI":"10.4048\/jbc.2020.23.e48","article-title":"Effect of adjuvant hormonal therapy on the development of pulmonary fibrosis after postoperative radiotherapy for breast cancer","volume":"23","author":"Anzic","year":"2020","journal-title":"J Breast Cancer"},{"key":"R24-20260512","first-page":"228\u201332","article-title":"Effects of hormonotherapy administered after concurrent radiotherapy and Trastuzumab on pulmonary fibrosis","volume":"17","author":"Benderli Cihan","year":"2013","journal-title":"Hippokratia"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"67\u201377","DOI":"10.1007\/s00066-022-02032-y","article-title":"Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy","volume":"199","author":"Mangesius","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"323","DOI":"10.21037\/atm-22-5062","article-title":"Organising pneumonia caused by hormone (tamoxifen) therapy after radiotherapy for breast cancer: a case report and review of the literature","volume":"11","author":"Zhong","year":"2023","journal-title":"Ann Transl Med"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"177980","DOI":"10.1016\/j.scitotenv.2024.177980","article-title":"Analyzing the potential targets and mechanisms of chronic kidney disease induced by common synthetic Endocrine Disrupting Compounds (EDCs) in Chinese surface water environment using network toxicology and molecular docking techniques","volume":"958","author":"Pei","year":"2025","journal-title":"Sci Total Environ"},{"key":"R28-20260512","first-page":"100082","article-title":"Transparency in the reporting of","volume":"10","author":"Agha","year":"2025","journal-title":"Artif Intell"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"1058\u201369","DOI":"10.1056\/NEJMra2116777","article-title":"Cryptogenic organizing pneumonia","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"508\u201312","DOI":"10.1016\/j.autrev.2014.01.037","article-title":"Diagnosis and classification of idiopathic pulmonary fibrosis","volume":"13","author":"Kekevian","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"810\u201320","DOI":"10.1111\/resp.12786","article-title":"Acute and subacute idiopathic interstitial pneumonias","volume":"21","author":"Taniguchi","year":"2016","journal-title":"Respirology"},{"key":"R33-20260512","first-page":"18\u201332","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"109995","DOI":"10.1016\/j.isci.2024.109995","article-title":"ESR1 and p53 interactome alteration defines mechanisms of tamoxifen response in luminal breast cancer","volume":"27","author":"Oturkar","year":"2024","journal-title":"iScience"},{"key":"R35-20260512","first-page":"4915\u201328","article-title":"Loss of estrogen-regulated MIR135A1 at 3p21.1 promotes tamoxifen resistance in breast cancer","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"1230266","DOI":"10.3389\/fimmu.2023.1230266","article-title":"Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis","volume":"14","author":"Lv","year":"2023","journal-title":"Front Immunol"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"526\u201338","DOI":"10.1016\/j.ijrobp.2020.12.035","article-title":"IGF-1 receptor signaling regulates Type II pneumocyte senescence and resulting macrophage polarization in lung fibrosis","volume":"110","author":"Chung","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"1712\u201321","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-024-07327-9","article-title":"Targeting EGFR-binding protein SLC7A11 enhancing antitumor immunity of T cells via inducing MHC-I antigen presentation in nasopharyngeal carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis"},{"key":"R40-20260512","doi-asserted-by":"crossref","first-page":"1355\u201363","DOI":"10.1158\/2159-8290.CD-13-0310","article-title":"Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors","volume":"3","author":"Akbay","year":"2013","journal-title":"Cancer Discov"},{"key":"R41-20260512","doi-asserted-by":"crossref","first-page":"2757\u201368","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant"},{"key":"R42-20260512","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41419-022-05370-y","article-title":"EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"R43-20260512","first-page":"599\u2013612","article-title":"Identification and consequences of miRNA-target interactions\u2013beyond repression of gene expression","volume":"15","author":"Hausser","year":"2014","journal-title":"Nat Rev Genet"},{"key":"R44-20260512","doi-asserted-by":"crossref","first-page":"147\u201354","DOI":"10.1016\/S1672-0229(08)60044-3","article-title":"A brief review on the mechanisms of miRNA regulation","volume":"7","author":"Cai","year":"2009","journal-title":"Genomics Proteomics Bioinf"},{"key":"R45-20260512","first-page":"71\u201386","article-title":"Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis","volume":"5","author":"McGee","year":"2014","journal-title":"Int J Mol Epidemiol Genet"},{"key":"R46-20260512","doi-asserted-by":"crossref","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"R47-20260512","doi-asserted-by":"crossref","first-page":"614\u201319","DOI":"10.1016\/j.bone.2015.07.034","article-title":"Optimizing tamoxifen-inducible Cre\/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice","volume":"81","author":"Zhong","year":"2015","journal-title":"Bone"},{"key":"R48-20260512","doi-asserted-by":"crossref","first-page":"27997\u20138011","DOI":"10.1021\/acsnano.4c06139","article-title":"Delineating, imaging, and assessing pulmonary fibrosis remodeling via collagen hybridization","volume":"18","author":"Zhao","year":"2024","journal-title":"ACS Nano"},{"key":"R49-20260512","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s13287-024-03945-4","article-title":"Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosis","volume":"15","author":"Song","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"R50-20260512","doi-asserted-by":"crossref","first-page":"193\u201397","DOI":"10.1038\/s41586-019-1064-z","article-title":"Genetic compensation triggered by mutant mRNA degradation","volume":"568","author":"El-Brolosy","year":"2019","journal-title":"Nature"},{"key":"R51-20260512","doi-asserted-by":"crossref","first-page":"1855\u201367","DOI":"10.3892\/ijo.2016.3401","article-title":"miR-223 reverses the resistance of EGFR-TKIs through IGF1R\/PI3K\/Akt signaling pathway","volume":"48","author":"Han","year":"2016","journal-title":"Int J Oncol"},{"key":"R52-20260512","doi-asserted-by":"crossref","first-page":"90\u201395","DOI":"10.1093\/annonc\/mdt399","article-title":"The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen","volume":"25","author":"Dieudonn\u00e9","year":"2014","journal-title":"Ann Oncol"},{"key":"R53-20260512","doi-asserted-by":"crossref","first-page":"1772\u201382","DOI":"10.1161\/CIRCULATIONAHA.114.013003","article-title":"Vascular signal transducer and activator of transcription-3 promotes angiogenesis and neuroplasticity long-term after stroke","volume":"131","author":"Hoffmann","year":"2015","journal-title":"Circulation"},{"key":"R54-20260512","first-page":"4837\u201344","article-title":"Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment","volume":"51","author":"Lien","year":"1991","journal-title":"Cancer Res"},{"key":"R55-20260512","doi-asserted-by":"crossref","first-page":"110675","DOI":"10.1016\/j.mce.2019.110675","article-title":"OECD approaches and considerations for regulatory evaluation of endocrine disruptors","volume":"504","author":"Browne","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"R56-20260512","first-page":"1913\u201321","article-title":"Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig","volume":"42","author":"Gulino","year":"1982","journal-title":"Cancer Res"},{"key":"R57-20260512","doi-asserted-by":"crossref","first-page":"310\u201318","DOI":"10.1016\/j.cbpc.2006.10.008","article-title":"Endocrine disrupters with (anti)estrogenic and (anti)androgenic modes of action affecting reproductive biology of Xenopus laevis: I. Effects on sex steroid levels and biomarker expression","volume":"144","author":"Urbatzka","year":"2007","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"R58-20260512","doi-asserted-by":"crossref","first-page":"918\u201322","DOI":"10.1093\/jnci\/88.13.918","article-title":"Radiotherapy-related lung fibrosis enhanced by tamoxifen","volume":"88","author":"Bentzen","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"R59-20260512","doi-asserted-by":"crossref","first-page":"137395","DOI":"10.1016\/j.jhazmat.2025.137395","article-title":"Exploring the reproductive exposure risks of phthalates and organophosphates in atmospheric particulate matter based on quantitative structure-activity relationships and network toxicology models","volume":"488","author":"Gao","year":"2025","journal-title":"J Hazard Mater"},{"key":"R60-20260512","doi-asserted-by":"crossref","first-page":"2307\u201316","DOI":"10.1182\/blood-2012-02-408252","article-title":"Induction of IL-4R\u03b1-dependent microRNAs identifies PI3K\/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo","volume":"120","author":"R\u00fcckerl","year":"2012","journal-title":"Blood"},{"key":"R61-20260512","doi-asserted-by":"crossref","first-page":"212\u201321","DOI":"10.1016\/j.apsb.2016.03.002","article-title":"Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K\/AKT and Ras\/MAPK pathways","volume":"6","author":"Hou","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"R62-20260512","doi-asserted-by":"crossref","first-page":"3056\u201373","DOI":"10.1002\/hep.32066","article-title":"Salidroside activates the AMP-Activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"R63-20260512","doi-asserted-by":"crossref","first-page":"4289\u201393","DOI":"10.1158\/0008-5472.CAN-11-3549","article-title":"Proteomic identification of a direct role for cyclin d1 in DNA damage repair","volume":"72","author":"Jirawatnotai","year":"2012","journal-title":"Cancer Res"},{"key":"R64-20260512","doi-asserted-by":"crossref","first-page":"1\u20138","DOI":"10.1016\/j.cancergen.2022.12.001","article-title":"Clinical impact of 5(\u2018)MYC or 3(\u2018)MYC gain\/loss detected by FISH in patients with aggressive B-cell lymphomas","volume":"272-273","author":"Tang","year":"2023","journal-title":"Cancer Genet"},{"key":"R65-20260512","doi-asserted-by":"crossref","first-page":"1555\u201373","DOI":"10.1038\/modpathol.2015.118","article-title":"Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"28","author":"Xu-Monette","year":"2015","journal-title":"Mod Pathol"},{"key":"R66-20260512","doi-asserted-by":"crossref","first-page":"180\u201389","DOI":"10.1016\/j.domaniend.2008.05.003","article-title":"Involvement of connective tissue growth factor (CTGF) in insulin-like growth factor-I (IGF1) stimulation of proliferation of a bovine mammary epithelial cell line","volume":"35","author":"Zhou","year":"2008","journal-title":"Domest Anim Endocrinol"},{"key":"R67-20260512","doi-asserted-by":"crossref","first-page":"875\u201383","DOI":"10.1016\/j.jhep.2005.04.011","article-title":"The intrahepatic biliary epithelium is a target of the growth hormone\/insulin-like growth factor 1 axis","volume":"43","author":"Alvaro","year":"2005","journal-title":"J Hepatol"},{"key":"R68-20260512","doi-asserted-by":"crossref","first-page":"819\u201341","DOI":"10.1007\/s11095-006-9216-x","article-title":"New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy","volume":"24","author":"Gharaee-Kermani","year":"2007","journal-title":"Pharm Res"},{"key":"R69-20260512","doi-asserted-by":"crossref","first-page":"bbaa289","DOI":"10.1093\/bib\/bbaa289","article-title":"Are dropout imputation methods for scRNA-seq effective for scHi-C data?","volume":"22","author":"Han","year":"2021","journal-title":"Brief Bioinform"},{"key":"R70-20260512","doi-asserted-by":"crossref","first-page":"C483","DOI":"10.1152\/ajpcell.00239.2023","article-title":"Senescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis","volume":"325","author":"Parimon","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"R71-20260512","doi-asserted-by":"crossref","first-page":"990874","DOI":"10.3389\/fimmu.2022.990874","article-title":"Akt isoforms in the immune system","volume":"13","author":"Guerau-de-arellano","year":"2022","journal-title":"Front Immunol"},{"key":"R72-20260512","doi-asserted-by":"crossref","first-page":"2296\u2013308","DOI":"10.1194\/jlr.M050633","article-title":"Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice","volume":"55","author":"Babaev","year":"2014","journal-title":"J Lipid Res"},{"key":"R73-20260512","doi-asserted-by":"crossref","first-page":"2259\u201368","DOI":"10.1253\/circj.CJ-16-0924","article-title":"Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis","volume":"80","author":"Linton","year":"2016","journal-title":"Circ J"},{"key":"R74-20260512","doi-asserted-by":"crossref","first-page":"1111393","DOI":"10.3389\/fphar.2023.1111393","article-title":"Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Pharmacol"},{"key":"R75-20260512","doi-asserted-by":"crossref","first-page":"235\u201342","DOI":"10.1007\/s00408-023-00608-8","article-title":"Deficiency of HtrA3 attenuates bleomycin-induced pulmonary fibrosis via TGF-\u03b21\/Smad signaling pathway","volume":"201","author":"Li","year":"2023","journal-title":"Lung"},{"key":"R76-20260512","doi-asserted-by":"crossref","first-page":"309\u201317","DOI":"10.1006\/abbi.2000.2095","article-title":"The juxtamembrane region of the epidermal growth factor receptor is required for phosphorylation of Galpha(s)","volume":"383","author":"Poppleton","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"R77-20260512","doi-asserted-by":"crossref","first-page":"41\u201353","DOI":"10.1016\/j.cytogfr.2023.03.003","article-title":"Multiple post-translational modifications ensure EGFR functionality: potential therapeutic targets to overcome its drug-resistance mutations","volume":"70","author":"He","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"R78-20260512","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cells11060986","article-title":"EGFR signaling in lung fibrosis","volume":"11","author":"Schramm","year":"2022","journal-title":"Cells"},{"key":"R79-20260512","doi-asserted-by":"crossref","first-page":"L1217","DOI":"10.1152\/ajplung.00020.2008","article-title":"EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis","volume":"294","author":"Hardie","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R80-20260512","doi-asserted-by":"crossref","first-page":"679\u201386","DOI":"10.2353\/ajpath.2010.090123","article-title":"Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis","volume":"176","author":"Le Cras","year":"2010","journal-title":"Am J Pathol"},{"key":"R81-20260512","first-page":"5054\u201359","article-title":"Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis","volume":"63","author":"Suzuki","year":"2003","journal-title":"Cancer Res"},{"key":"R82-20260512","doi-asserted-by":"crossref","first-page":"305\u201321","DOI":"10.1002\/1878-0261.12162","article-title":"TGF-\u03b2 transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK\/Sp1 signaling pathways","volume":"12","author":"Zhao","year":"2018","journal-title":"Mol Oncol"},{"key":"R83-20260512","doi-asserted-by":"crossref","first-page":"843\u201354","DOI":"10.1083\/jcb.200106056","article-title":"Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies","volume":"156","author":"Longva","year":"2002","journal-title":"J Cell Biol"},{"key":"R84-20260512","doi-asserted-by":"crossref","first-page":"4407\u201321","DOI":"10.1096\/fj.201601359RR","article-title":"Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis","volume":"31","author":"Overstreet","year":"2017","journal-title":"Faseb j"},{"key":"R85-20260512","doi-asserted-by":"crossref","first-page":"540\u201352","DOI":"10.1159\/000515279","article-title":"Hsa Circ 001839 promoted inflammation in renal ischemia-reperfusion injury through NLRP3 by miR-432-3p","volume":"145","author":"Hou","year":"2021","journal-title":"Nephron"},{"key":"R86-20260512","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41419-020-03178-2","article-title":"Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial-mesenchymal transition and inflammation","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis"},{"key":"R87-20260512","first-page":"e1806","article-title":"Tamoxifen use and risk of endometrial cancer in breast cancer patients: a systematic review and dose-response meta-analysis","volume":"6","author":"Ghanavati","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"R88-20260512","doi-asserted-by":"crossref","first-page":"2887\u201390","DOI":"10.1002\/oby.23927","article-title":"Challenges in undertaking nonlinear Mendelian randomization","volume":"31","author":"Wade","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"R89-20260512","doi-asserted-by":"crossref","first-page":"812748","DOI":"10.3389\/fcell.2021.812748","article-title":"Resident fibroblast MKL1 is sufficient to drive pro-fibrogenic response in Mice","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R90-20260512","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/ATVBAHA.123.318926","article-title":"Cytokine-mediated degradation of the transcription factor ERG impacts the pulmonary vascular response to systemic inflammatory challenge","volume":"43","author":"Schafer","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R91-20260512","doi-asserted-by":"crossref","first-page":"198\u2013211","DOI":"10.1164\/rccm.201902-0451OC","article-title":"Grp78 loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis","volume":"201","author":"Borok","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R92-20260512","doi-asserted-by":"crossref","first-page":"e172977","DOI":"10.1172\/jci.insight.172977","article-title":"PGF2\u03b1 signaling drives fibrotic remodeling and fibroblast population dynamics in mice","volume":"8","author":"Rodriguez","year":"2023","journal-title":"JCI Insight"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:15:23Z","timestamp":1778580923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003620","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"2025-06-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}